Steven M. Strasberg
Experienced in Gastrectomy

Dr. Steven M. Strasberg

General Surgery
4921 Parkview Pl Ste 8c, Ste 8c, 
Saint Louis, MO 
Experienced in Gastrectomy
4921 Parkview Pl Ste 8c, Ste 8c, 
Saint Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Steven Strasberg is a General Surgeon in Saint Louis, Missouri. Dr. Strasberg is rated as an Experienced provider by MediFind in Gastrectomy. His top areas of expertise are Gallbladder Disease, Cholecystitis, Pancreatic Cancer, Gallbladder Removal, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 128 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Gastrectomy.

Specialties
General Surgery
Licenses
Surgery in MO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

4921 Parkview Pl Ste 8c, Ste 8c, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Phase II Study of Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma
Phase II Study of Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: September 23, 2025
Intervention Type: Procedure, Device, Drug
Study Drug: Defactinib
Study Phase: Phase 2
A Phase I/II Study to Evaluate the Tolerability and Efficacy of BMS-813160 (CCR2/5 Inhibitor) With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
A Phase I/II Study to Evaluate the Tolerability and Efficacy of BMS-813160 (CCR2/5 Inhibitor) With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Drug, Procedure
Study Drugs: BMS-813160, Nivolumab, Gemcitabine, Nab-paclitaxel
Study Phase: Phase 1/Phase 2
The Effect of Preoperative and Postoperative Incentive Spirometry in Patients Undergoing Major Abdominal Surgery
The Effect of Preoperative and Postoperative Incentive Spirometry in Patients Undergoing Major Abdominal Surgery
Enrollment Status: Terminated
Publish Date: May 17, 2023
Intervention Type: Device
Study Phase: Not Applicable
Remote Telemonitoring to Improve Prehabilitation and Surgical Outcomes of Patients Undergoing Elective Abdominal Surgery
Remote Telemonitoring to Improve Prehabilitation and Surgical Outcomes of Patients Undergoing Elective Abdominal Surgery
Enrollment Status: Terminated
Publish Date: December 12, 2022
Intervention Type: Other
Study Phase: Not Applicable
Pilot Study of Hepatic Arterial Infusion Therapy in Patients With Unresectable or Borderline Resectable Intrahepatic Cholangiocarcinoma
Pilot Study of Hepatic Arterial Infusion Therapy in Patients With Unresectable or Borderline Resectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Drug
Study Phase: Phase 1
Evaluation of Fluorescence Imaging in Hepatobiliary Surgery
Evaluation of Fluorescence Imaging in Hepatobiliary Surgery
Enrollment Status: Withdrawn
Publish Date: January 24, 2022
Intervention Type: Device
Study Phase: Not Applicable
Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement
Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement
Enrollment Status: Terminated
Publish Date: May 15, 2020
Intervention Type: Other
Study Phase: Not Applicable
Epidural Analgesia Use in Pancreatic Resections
Epidural Analgesia Use in Pancreatic Resections
Enrollment Status: Completed
Publish Date: March 12, 2020
Intervention Type: Drug
Study Phase: Phase 1
Prospective Phase I Study of Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer
Prospective Phase I Study of Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer
Enrollment Status: Completed
Publish Date: June 19, 2019
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Whipple at the Splenic Artery - A Procedure for Ductal Adenocarcinoma of the Pancreas With Extensive Involvement of the Porto-Mesenteric Axis: A Registry Study
Whipple at the Splenic Artery - A Procedure for Ductal Adenocarcinoma of the Pancreas With Extensive Involvement of the Porto-Mesenteric Axis: A Registry Study
Enrollment Status: Completed
Publish Date: January 22, 2019
Intervention Type: Procedure
Thunderbeat™ Integrated Bipolar and Ultrasonic Forceps in the Whipple Procedure: A Prospective Registry Trial
Thunderbeat™ Integrated Bipolar and Ultrasonic Forceps in the Whipple Procedure: A Prospective Registry Trial
Enrollment Status: Terminated
Publish Date: September 19, 2018
Intervention Type: Device
Study Phase: Not Applicable
4D Phase Contrast MR: Validation and Evaluation of Hypertrophy in Liver Cancer
4D Phase Contrast MR: Validation and Evaluation of Hypertrophy in Liver Cancer
Enrollment Status: Terminated
Publish Date: April 07, 2017
Intervention Type: Procedure, Device
Study Phase: Not Applicable
View 11 Less Clinical Trials

128 Total Publications

Re: Anatomical appraisal of safe cholecystectomy: a prospective study.
Re: Anatomical appraisal of safe cholecystectomy: a prospective study.
Journal: ANZ journal of surgery
Published: October 06, 2023
Similar Doctors
Distinguished in Gastrectomy
Dr. Ryan C. Fields
Surgical Oncology | General Surgery | Emergency Medicine
Distinguished in Gastrectomy
Dr. Ryan C. Fields
Surgical Oncology | General Surgery | Emergency Medicine

Washington University

216 S Kingshighway Blvd, 
Saint Louis, MO 
 (0.9 miles away)
314-362-9355
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ryan Fields is a Surgical Oncologist and a General Surgeon in Saint Louis, Missouri. Dr. Fields is rated as an Elite provider by MediFind in Gastrectomy. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Gallbladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fields is currently accepting new patients.

Advanced in Gastrectomy
Dr. Danny Mou
General Surgery
Advanced in Gastrectomy
Dr. Danny Mou
General Surgery

Washington University

1 Barnes Jewish Hospital Plz, 
Saint Louis, MO 
 (0.7 miles away)
314-273-7373
Languages Spoken:
English, Mandarin, Spanish
See accepted insurances
Accepting New Patients

Danny Mou is a General Surgeon in Saint Louis, Missouri. Dr. Mou is rated as an Advanced provider by MediFind in Gastrectomy. His top areas of expertise are Obesity, Hiatal Hernia, Gastroesophageal Reflux Disease (GERD), Sleeve Gastrectomy, and Gastrectomy. Dr. Mou is currently accepting new patients.

Advanced in Gastrectomy
Dr. John C. Eagon
General Surgery
Advanced in Gastrectomy
Dr. John C. Eagon
General Surgery

Washington University

1 Barnes Jewish Hospital Plz, Suite 200, 
Saint Louis, MO 
 (0.7 miles away)
314-273-7373
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Eagon is a General Surgeon in Saint Louis, Missouri. Dr. Eagon is rated as a Distinguished provider by MediFind in Gastrectomy. His top areas of expertise are Obesity, Malabsorption, Obesity in Children, Gastric Bypass, and Sleeve Gastrectomy. Dr. Eagon is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Strasberg's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 35 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile